A century of oncolysis evolves into oncolytic immunotherapy

Por Hemminki, O., Hemminki, A.
Publicado no Oncoimmunology (2015)

Population Landscape of Familial Cancer

Por Frank, C., Fallah, M., Sundquist, J., Hemminki, A., Hemminki, K.
Publicado no Sci Rep (2015)

Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues

Por Zheng G, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K
Publicado em 2020-08-01

A three-dimensional assay for measurement of viral-induced oncolysis

Por Lam, JT, Hemminki, A, Kanerva, A, Lee, KB, Blackwell, JL, Desmond, R, Siegal, GP, Curiel, DT
Publicado em 2007

A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Δ24, for the treatment of advanced breast cancer

Por Ranki, T, Kanerva, A, Ristimäki, A, Hakkarainen, T, Särkioja, M, Kangasniemi, L, Raki, M, Laakkonen, P, Goodison, S, Hemminki, A
Publicado em 2006

Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3.

Por Olschwang, S, Markie, D, Seal, S, Neale, K, Phillips, R, Cottrell, S, Ellis, I, Hodgson, S, Zauber, P, Spigelman, A, Iwama, T, Loff, S, McKeown, C, Marchese, C, Sampson, J, Davies, S, Talbot, I, Wyke, J, Thomas, G, Bodmer, W, Hemminki, A, Avizienyte, E, de la Chapelle, A, Aaltonen, L, Tomlinson, I
Publicado em 1998

Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8(+) T-cell response and robust cellular and transcriptional immune activation at tumor site in a pa...

Por Vassilev, L, Ranki, T, Joensuu, T, Jäger, E, Karbach, J, Wahle, C, Partanen, K, Kairemo, K, Alanko, T, Turkki, R, Linder, N, Lundin, J, Ristimäki, A, Kankainen, M, Hemminki, A, Backman, C, Dienel, K, von Euler, M, Haavisto, E, Hakonen, T, Juhila, J, Jäderberg, M, Priha, P, Vuolanto, A, Pesonen, S
Publicado no Oncoimmunology (2015)